======= SLC34A1 ======= == Gene Information == * **Official Symbol**: SLC34A1 * **Official Name**: solute carrier family 34 member 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6569|6569]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q06495|Q06495]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC34A1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC34A1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/182309|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the type II sodium-phosphate cotransporter family. Mutations in this gene are associated with hypophosphatemia nephrolithiasis/osteoporosis 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2009]. * **UniProt Summary**: Involved in actively transporting phosphate into cells via Na(+) cotransport in the renal brush border membrane. Probably mediates 70-80% of the apical influx. {ECO:0000269|PubMed:26047794, ECO:0000269|PubMed:8327470}. |Na Pi cotrans| |regulation of phosphate transmembrane transport| |indole metabolic process| |positive regulation of phosphate transmembrane transport| |gentamycin metabolic process| |arsenate ion transmembrane transport| |positive regulation of sodium-dependent phosphate transport| |positive regulation of inorganic anion transmembrane transport| |cellular response to staurosporine| |sodium-dependent phosphate transmembrane transporter activity| |response to staurosporine| |sodium-dependent phosphate transport| |regulation of sodium-dependent phosphate transport| |regulation of inorganic anion transmembrane transport| |dentinogenesis| |positive regulation of anion transmembrane transport| |sodium:phosphate symporter activity| |cellular phosphate ion homeostasis| |cellular trivalent inorganic anion homeostasis| |regulation of phosphate transport| |cellular divalent inorganic anion homeostasis| |cellular response to parathyroid hormone stimulus| |aminoglycoside antibiotic metabolic process| |response to mercury ion| |trivalent inorganic anion homeostasis| |cellular anion homeostasis| |phosphate ion homeostasis| |response to parathyroid hormone| |cellular monovalent inorganic anion homeostasis| |divalent inorganic anion homeostasis| |tricarboxylic acid metabolic process| |positive regulation of membrane potential| |sodium ion import across plasma membrane| |response to potassium ion| |phosphate ion transmembrane transport| |response to vitamin A| |response to magnesium ion| |glycoside metabolic process| |phosphate ion transport| |response to lead ion| |indole-containing compound metabolic process| |response to thyroid hormone| |monovalent inorganic anion homeostasis| |regulation of anion transmembrane transport| |response to growth hormone| |cellular response to alkaloid| |positive regulation of anion transport| |brush border| |brush border membrane| |anion homeostasis| |response to cadmium ion| |inorganic cation import across plasma membrane| |inorganic ion import across plasma membrane| |mitotic spindle| |odontogenesis of dentin-containing tooth| |response to vitamin| |PDZ domain binding| |sodium ion transmembrane transport| |regulation of anion transport| |import across plasma membrane| |antibiotic metabolic process| |inorganic anion transmembrane transport| |polyol metabolic process| |response to alkaloid| |odontogenesis| |cellular response to ammonium ion| |glycosyl compound metabolic process| |response to estradiol| |vesicle| |sodium ion transport| |positive regulation of ion transmembrane transport| |inorganic anion transport| |response to ammonium ion| |cellular response to metal ion| |positive regulation of transmembrane transport| |response to nutrient| |cellular response to inorganic substance| |membrane raft| |ossification| |protein-containing complex binding| |kidney development| |endosome| |positive regulation of ion transport| |anion transmembrane transport| |renal system development| |alcohol metabolic process| |apical plasma membrane| |urogenital system development| |protein homooligomerization| |response to metal ion| |glycoprotein metabolic process| |response to peptide hormone| |monovalent inorganic cation transport| |nuclear speck| |regulation of membrane potential| |organic hydroxy compound metabolic process| |response to peptide| |regulation of ion transmembrane transport| |response to nutrient levels| |drug metabolic process| |protein complex oligomerization| |response to extracellular stimulus| |response to inorganic substance| |cellular response to organic cyclic compound| |inorganic cation transmembrane transport| |regulation of transmembrane transport| |anion transport| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |cation transmembrane transport| |cell surface| |metal ion transport| |cellular ion homeostasis| |inorganic ion transmembrane transport| |cellular response to nitrogen compound| |import into cell| |perinuclear region of cytoplasm| |regulation of ion transport| |inorganic ion homeostasis| |cellular chemical homeostasis| |ion homeostasis| |cation transport| |response to lipid| |protein homodimerization activity| |anatomical structure formation involved in morphogenesis| |cellular homeostasis| |carboxylic acid metabolic process| |response to hormone| |response to organic cyclic compound| |ion transmembrane transport| |animal organ morphogenesis| |positive regulation of transport| |response to organonitrogen compound| |oxoacid metabolic process| |response to drug| |organic acid metabolic process| |carbohydrate derivative metabolic process| |response to nitrogen compound| |chemical homeostasis| |cellular response to endogenous stimulus| |transmembrane transport| |ion transport| |integral component of plasma membrane| |response to endogenous stimulus| |response to oxygen-containing compound| |protein-containing complex assembly| |homeostatic process| |small molecule metabolic process| |protein-containing complex subunit organization| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|-2.03| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|-1.71| ^Gene^Correlation^ |[[:human genes:r:rrm1|RRM1]]|0.419| Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|1/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12685 * **Expression level (log2 read counts)**: -5.6 {{:chemogenomics:nalm6 dist.png?nolink |}}